Safe CAR-T: shedding light on CAR-related T-cell malignancies
Sign Up to like & getrecommendations! Published in 2025 at "EMBO Molecular Medicine"
DOI: 10.1038/s44321-025-00205-7
Abstract: As of September 30, 2023, the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database has received 12 reports of secondary T-cell malignancies since the first of the BCMA-/CD19-targeted autologous CAR-T therapies was… read more here.
Keywords: car; cell; shedding light; safe car ... See more keywords